From the Toronto Star:
U.S. takes aim at cheaper drugs
The bill, which President George Bush will sign into law Monday, forbids the government from using its purchasing power to negotiate better prices with the pharmaceutical industry.

It also requires a study to be undertaken of price controls used in other countries that may hinder the profitability of U.S.-based pharmaceutical companies. Having foresworn the use of price controls in their own market, a number of American politicians now hope to dismantle those in other countries.

Dennis Hastert, the Republican Speaker of the House of Representatives, has lobbied the White House to use international trade rules to challenge Canada's price controls, which are administered by our Patented Medicine Prices Review Board. It's something that the pharmaceutical industry has been pushing for years.

From the Allentown (PA) Times:
Cheaper prescriptions shipped into Canada and back to USA
As for his own patriotism, Syed pointed to many of those who use Rx4uNOW who are former Armed Services members, or who are just patriots in their own right.

"It's hard for them to use another country to get their medication," he said. "They are proud of America and love it. They don't want to have to do this, but the alternatives aren't very good."

From the Oregon News Review:
Roseburg issues license to Canada Drug Supply
In a reversal of an earlier decision, the city of Roseburg has issued a business registration to Canada Drug Supply.

City Manager Randy Wetmore sided with the owners of the business after considering testimony presented during an appeals hearing held Wednesday. Wetmore said he decided to leave any broad policy decisions concerning the importation of drugs from Canadian pharmacies to higher authorities.

"We decided that the state Board of Pharmacy should really be the ones to make any decision," Wetmore said this morning. "It's a state or federal enforcement issue, rather than a city enforcement issue."

From MSNBC:
Ad, letter aimed at Boston firms
In an assault evoking images of rivalry dating from the Civil War, a North Carolina biosciences group has taken out a pricey full-page ad in The Boston Globe, pitching Massachusetts biotech companies to move their operations to or grow them in the Tar Heel State.